Cardiac cachexia is a multifaceted and severe syndrome characterized by the involuntary weight loss, muscle wasting, and debility seen in individuals grappling with chronic heart failure. This syndrome extends beyond simple weight reduction, involving a profound depletion of both lean body mass and fat reserves. Its management presents a considerable challenge in the context of heart failure, often resulting in heightened morbidity and mortality rates. The intricate mechanisms underlying cardiac cachexia encompass a intricate interplay of inflammatory processes, hormonal imbalances, and metabolic disruptions. Clinically, individuals afflicted by cardiac cachexia witness a decline in their functional capacity, coupled with a compromised quality of life. Approaches to managing this syndrome typically necessitate a multidisciplinary strategy, emphasizing nutritional support, exercise rehabilitation, and addressing the root causes of heart failure. Ongoing research delving into the pathophysiology and treatment avenues for cardiac cachexia aspires to deepen our comprehension and enhance the prognosis for those affected by this incapacitating syndrome.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation